Jeff Garro

Stock Analyst at Stephens & Co.

(1.84)
# 3,301
Out of 5,044 analysts
54
Total ratings
37.84%
Success rate
-7.8%
Average return

Stocks Rated by Jeff Garro

Privia Health Group
Sep 24, 2025
Reiterates: Overweight
Price Target: $32
Current: $25.60
Upside: +25.00%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $7.08
Upside: +27.12%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $23.22
Upside: +37.81%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28$20
Current: $17.79
Upside: +12.42%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $19.49
Upside: +43.66%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $286.67
Upside: -2.33%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7$5
Current: $3.34
Upside: +49.70%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.58
Upside: +46.80%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.77
Upside: +80.51%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $66.77
Upside: -17.63%
Initiates: Equal-Weight
Price Target: $5.5
Current: $20.56
Upside: -73.25%
Initiates: Overweight
Price Target: $250
Current: $217.83
Upside: +14.77%
Initiates: Buy
Price Target: $17
Current: $20.54
Upside: -17.23%
Reiterates: Equal-Weight
Price Target: $28
Current: $8.23
Upside: +240.22%
Maintains: Overweight
Price Target: $15$20
Current: $18.21
Upside: +9.83%
Maintains: Underweight
Price Target: $5$3.9
Current: $4.82
Upside: -19.09%
Maintains: Neutral
Price Target: $4$3
Current: $2.11
Upside: +42.18%